Basket cover image
15 handpicked stocks

Trust Brokers

In today's uncertain world, these carefully selected companies profit by providing essential security, validation, and certification services. They sell trust itself—a non-discretionary commodity that commands premium pricing and ensures reliable demand regardless of economic conditions.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at जून 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

MCO

Moody's Corporation

MCO

Current price

$512.00

It provides essential credit ratings and risk analysis that underpin trust in global capital markets.

CRWD

CrowdStrike Holdings, Inc.

CRWD

Current price

$418.60

Its cloud-native platform provides endpoint security, ensuring trust in the devices used across an organization.

PANW

Palo Alto Networks, Inc.

PANW

Current price

$181.56

As a leader in enterprise cybersecurity, it provides a comprehensive security platform that enables organizations to operate with confidence.

About This Group of Stocks

1

Our Expert Thinking

As global systems grow more complex and threats become more sophisticated, businesses that provide verification, security, and trust services enjoy increasing demand. These companies have transformed trust from an intangible concept into a profitable business model with strong pricing power.

2

What You Need to Know

This collection includes leaders in cybersecurity, credit rating agencies, and specialized consultancies. Their services remain essential regardless of economic cycles, making them potential defensive anchors in a diversified portfolio. Many benefit directly from the rise of AI and increasingly complex digital threats.

3

Why These Stocks

We've selected market leaders whose names have become synonymous with reliability and authoritative judgment. Each company has established a significant competitive moat by becoming the gold standard in their field, whether in cybersecurity, financial ratings, or high-stakes consulting.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+19.71%

Group Performance Snapshot

19.71%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 19.71% over the next year.

15 of 15

Stocks Rated Buy by Analysts

15 of 15 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🛡️

Rising Threats, Rising Profits

As cyber threats and AI-powered scams grow more sophisticated, companies that provide security solutions are seeing surging demand. It's a case of bad news for the world but good news for investors.

💎

Recession-Resistant Reliability

Trust services aren't luxuries companies cut during downturns—they're essential costs of doing business. This makes these stocks potentially more stable when markets get rocky.

🔍

The Hidden Infrastructure of Trust

While consumers rarely interact with these companies directly, they power the trust systems that make our digital and financial lives possible. Without them, modern commerce would grind to a halt.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.